March 12, 2009
$46.8 billion: Basel-based Roche acquires rest of SF's Genentech.
GENEVA (March 12)--Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn’t already own, ending a long corporate struggle with its U.S.-based cancer drug partner. [more]
Posted by JD Hull at March 12, 2009 11:59 PM